ARK Genomic Revolution ETF $ARKG Shares Sold by Client First Investment Management LLC

Client First Investment Management LLC cut its position in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 64.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 21,953 shares of the company’s stock after selling 39,368 shares during the period. ARK Genomic Revolution ETF comprises about 0.6% of Client First Investment Management LLC’s investment portfolio, making the stock its 20th largest position. Client First Investment Management LLC’s holdings in ARK Genomic Revolution ETF were worth $1,190,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. Baird Financial Group Inc. lifted its position in ARK Genomic Revolution ETF by 0.3% in the second quarter. Baird Financial Group Inc. now owns 73,722 shares of the company’s stock worth $3,101,000 after purchasing an additional 255 shares during the period. Farther Finance Advisors LLC increased its holdings in ARK Genomic Revolution ETF by 22.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,914 shares of the company’s stock valued at $104,000 after buying an additional 348 shares during the period. PNC Financial Services Group Inc. increased its holdings in ARK Genomic Revolution ETF by 53.2% in the 1st quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock valued at $29,000 after buying an additional 378 shares during the period. Rockefeller Capital Management L.P. raised its stake in shares of ARK Genomic Revolution ETF by 1.9% in the 4th quarter. Rockefeller Capital Management L.P. now owns 24,243 shares of the company’s stock valued at $702,000 after buying an additional 461 shares in the last quarter. Finally, GK Wealth Management LLC acquired a new position in shares of ARK Genomic Revolution ETF in the 3rd quarter valued at $27,000.

ARK Genomic Revolution ETF Stock Up 4.1%

BATS:ARKG opened at $51.30 on Friday. The company has a 50-day moving average of $48.13 and a 200-day moving average of $38.64. ARK Genomic Revolution ETF has a 52 week low of $24.60 and a 52 week high of $58.83.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.